-
Archives
- December 2017
- June 2017
- May 2017
- February 2017
- November 2016
- October 2016
- September 2016
- July 2016
- April 2016
- March 2016
- December 2015
- August 2015
- April 2015
- February 2015
- January 2015
- December 2014
- November 2014
- September 2014
- August 2014
- July 2014
- May 2014
- January 2014
- December 2013
- November 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
-
Meta
Category Archives: drugs
Are Pediatric Guidelines for Statins Too Aggressive?
If, instead of following the adult guidelines, doctors used pediatric guidelines to identify teens with high LDL-levels, and if universal screening was in place, another 400,000 adolescents would be taking statins. Would that increase be good or bad? Doctors disagree. … Continue reading
Posted in drugs, pediatrics
Tagged guidelines, LDL, statins
Comments Off on Are Pediatric Guidelines for Statins Too Aggressive?
2014 Drug Issues: Where’s the Data, Product Hopping, Inappropriate Use, and What’s Come and Gone
For 2015, I’d love to see headway in clamping down on drugs that don’t work, tighter regulation of inappropriate drug marketing, and more open data and transparency from industry. Is it pie-in-the-sky? Maybe. But let’s work towards it. Patients need to … Continue reading
Posted in drugs
Tagged drug reviews, Namenda, patent hopping, Provenge, Tamiflu
Comments Off on 2014 Drug Issues: Where’s the Data, Product Hopping, Inappropriate Use, and What’s Come and Gone